Operational cash flow remains negative at $6.6 million for 2025Q4, forcing a continued reliance on external capital markets to fund the high-cost, first-of-a-kind nuclear engineering requirements.
| Cash from Operations | -10.3M | -41.19K | -3.89K |
| Operating CF Growth % | -24897.57% | -959.19% | - |
| Operating CF / Revenue % | - | - | - |
| Net Income | 539.52M | -33.58K | -4.47K |
| Depreciation & Amortization | 10K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | -554.01M | 0 | 699 |
| Working Capital Changes | 4.17M | -7.61K | -116 |
| Capital Expenditures | -108K | -230M | 0 |
| CapEx / Revenue % | - | - | - |
| CapEx / D&A | 10.80x | - | - |
| CapEx Coverage (OCF/CapEx) | -95.34x | -0.00x | - |
| Cash from Investing | -108K | -230M | 0 |
| Acquisitions | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 |
| Other Investing | 0 | -230M | 0 |
| Cash from Financing | 112.26M | 111.58K | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Dividend Payout Ratio % | - | - | - |
| Debt Issuance (Net) | 1000K | 111.58K | 0 |
| Stock Issued | 0 | 232.47M | 0 |
| Share Repurchases | 0 | 0 | 0 |
| Other Financing | 106.69M | -232.47M | 0 |
| Net Change in Cash | 102.81M | 67.26K | 1.68K |
| Exchange Rate Effect | 955K | -3.13K | 93 |
| Cash at Beginning | 69K | 1.68K | 0 |
| Cash at End | 102.88M | 68.93K | 1.68K |
| Free Cash Flow | -10.4M | -230.04M | -3.89K |
| FCF Growth % | 95.48% | -5915075.93% | - |
| FCF Margin % | - | - | - |
| FCF / Net Income % | -1.93% | 685033.78% | 86.96% |
Regulatory and execution bottleneck
As indicated by the latest financial disclosures, NKLR currently generates no operating cash flow from regulated activities, with the 2025Q4 period showing a negative operating cash flow of $6.6 million, underscoring the company's status as a pre-revenue entity rather than an established utility provider.
The lack of positive operating cash flow is expected for a firm in the developmental stage of nuclear technology. Investors should monitor the transition from R&D-heavy spending to the establishment of Power Purchase Agreements, which will be necessary to generate the predictable cash flows required for long-term sustainability.
Based on reported figures, NKLR's capital expenditure profile remains highly volatile, with a significant $230 million investment recorded in 2024Q4, reflecting the massive upfront costs associated with first-of-a-kind nuclear reactor engineering and the necessary infrastructure for a closed fuel cycle strategy.
This level of capital intensity suggests that the company is prioritizing long-term asset development over immediate cash preservation. The ability to manage these expenditures without diluting shareholders further will be a critical test of management's capital allocation strategy as they move toward commercialization.
According to historical financial statements, NKLR has relied heavily on equity issuance to fund its operations, notably raising $232.5 million in 2024Q4 to offset substantial cash burn, which highlights the company's current dependence on external capital markets to sustain its developmental roadmap.
The company's ability to secure additional funding on reasonable terms appears contingent upon hitting key regulatory milestones with European authorities. Any delay in these approvals may force the firm to seek more expensive financing, potentially increasing the cost of capital and impacting future project viability.
As reported in financial statements, the 2025Q4 net income of $539.4 million stands in stark contrast to the negative $6.6 million in operating cash flow, suggesting that non-operating gains are significantly distorting the company's true cash-generating capacity at this stage of its lifecycle.
Investors should exercise caution when interpreting these GAAP figures, as they do not reflect the underlying cash burn required to maintain the company's R&D and regulatory licensing efforts. The discrepancy between reported earnings and cash flow warrants further investigation into the nature of these non-recurring accounting items.
Quick answers to the most common questions about buying NKLR stock.
Terra Innovatum Global N.V. Ordinary shares (NKLR) generated $-10.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Terra Innovatum Global N.V. Ordinary shares (NKLR) reported negative free cash flow of $10.4M in 2025, indicating capital requirements exceeded cash from operations.
Terra Innovatum Global N.V. Ordinary shares (NKLR) spent $0.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.